Adamas Pharmaceuticals, Inc. announced the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients.
The US Food and Drug Administration approved Tekamlo (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna, with the widely used calcium channel blocker amlodipine.
Wheaton Science Products has announced that its CryoELITE Cryogenic Vials are CE marked in accordance with the requirements of Directive 8/79/EC on in vitro diagnostic medical devices.
VICI Valco’s Cheminert C52 Series Injector presents its first integrated motor/valve assembly designed specifically to be built into an OEM system.
Chindex International sold $14 million of its shares to another Chinese medical concern as part of its plans to form a new joint venture, the company said.
Ambry Genetics, a global leader in genomic services, announced that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System.
For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables.
Scientists at the University of East Anglia, have shown that fungus-farming ants are using multiple antibiotics as weed killers to maintain their fungus gardens.
Genentech announced the U.S. Food and Drug Administration issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA).
Shire plc announced that the European Commission has granted marketing authorisation for VPRIV (velaglucerase alfa), a human cell line derived enzyme replacement therapy for the long-term treatment of type 1 Gaucher disease.
Gov. Brian Schweitzer, cooking up a new plan to get cheaper prescription drugs for state residents, said he wants to let every Montanan get discounted medicine through Medicaid.
The European Medicines Agency has issued a statement saying that there have been a "limited" number of narcolepsy cases in people mainly in Sweden and Finland who got the Pandemrix shot, made by GlaxoSmithKline PLC.
In the United States, over eight million adults over age 50 suffer from peripheral arterial disease (PAD), a serious condition that commonly results from progressive narrowing of arteries in the lower extremities due to atherosclerosis.
Gilson, Inc. introduces a personal bench top purification system. The Gilson PLC 2020 Personal Purification System provides a complete, compact design with interchangeable pump heads.
Lonza’s 4D-Nucleofector System is lifting the Amaxa Nucleofector Technology to the next dimension. Lonza engineers and scientists have developed a system which is designed for maximum flexibility combined with advanced performance and convenience.